Latest Breaking News On - Patients with advanced solid - Page 1 : comparemela.com

FDA Grants ODD to Utidelone Capsules For Treatment of Gastric Cancer

The orphan drug designation is a result of positive findings from a phase 2 clinical trial which demonstrated a 100% clinical benefit rate in patients.

ChemoCentryx Announces Abstracts at June Rheumatology, Oncology and Nephrology Conferences

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Alkermes Presents New Data on Nemvaleukin Alfa at 2021 American Society of Clinical Oncology Annual Meeting

/PRNewswire/ Alkermes plc (Nasdaq: ALKS) today announced new data from its ARTISTRY clinical development program for nemvaleukin alfa (nemvaleukin),.

Alkermes to Host Webcast With Expert Oncologist Panel to Discuss Data on Nemvaleukin Alfa Presented at 2021 American Society of Clinical Oncology (ASCO) Annual Meeting

- Webcast to be Held at 4:00 p.m. ET on Friday, June 4 - DUBLIN, May 28, 2021 /PRNewswire/ Alkermes plc (Nasdaq: ALKS) today announced that it will host a webcast and conference call

Alkermes to Host Webcast With Expert Oncologist Panel to Discuss Data on Nemvaleukin Alfa Presented at 2021 American Society of Clinical Oncology (ASCO) Annual Meeting